EV Biologics YECO Stock
EV Biologics Price Chart
EV Biologics YECO Financial and Trading Overview
| EV Biologics stock price | 0.09 USD |
| Previous Close | 0.95 USD |
| Open | 0.95 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.95 - 0.95 USD |
| 52 Week Range | 0.25 - 2.34 USD |
| Volume | 1 USD |
| Avg. Volume | 177 USD |
| Market Cap | 40.63M USD |
| Beta (5Y Monthly) | -1.095774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32 USD |
YECO Valuation Measures
| Enterprise Value | 36.07M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.288073 |
| Price/Book (mrq) | 0.05423303 |
| Enterprise Value/Revenue | 3.807 |
| Enterprise Value/EBITDA | N/A |
Trading Information
EV Biologics Stock Price History
| Beta (5Y Monthly) | -1.095774 |
| 52-Week Change | 84.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.34 USD |
| 52 Week Low | 0.25 USD |
| 50-Day Moving Average | 0.96 USD |
| 200-Day Moving Average | 0.89 USD |
YECO Share Statistics
| Avg. Volume (3 month) | 177 USD |
| Avg. Daily Volume (10-Days) | 10 USD |
| Shares Outstanding | 28.41M |
| Float | 27.41M |
| Short Ratio | 0.12 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 91.37K |
| Short % of Float | 0.33% |
| Short % of Shares Outstanding | 0.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2017 |
| Most Recent Quarter (mrq) | June 30, 2017 |
| Next Fiscal Year End | December 31, 2018 |
Profitability
| Profit Margin | -5.82% |
| Operating Margin (ttm) | 1.63% |
| Gross Margin | 16.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 9.47M USD |
| Revenue Per Share (ttm) | 3.93 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.54M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -551581 USD |
| Diluted EPS (ttm) | -1.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.81M USD |
| Total Cash Per Share (mrq) | 0.07 USD |
| Total Debt (mrq) | 11.85M USD |
| Total Debt/Equity (mrq) | 318.53 USD |
| Current Ratio (mrq) | 3.113 |
| Book Value Per Share (mrq) | 17.517 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of EV Biologics
| Country | United States |
| State | WY |
| City | Cheyenne |
| Address | 1621 Central Avenue |
| ZIP | 82001 |
| Phone | 206-734-4738 |
| Website | https://www.evbiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 284 |
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
Q&A For EV Biologics Stock
What is a current YECO stock price?
EV Biologics YECO stock price today per share is 0.09 USD.
How to purchase EV Biologics stock?
You can buy YECO shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EV Biologics?
The stock symbol or ticker of EV Biologics is YECO.
Which industry does the EV Biologics company belong to?
The EV Biologics industry is Biotechnology.
How many shares does EV Biologics have in circulation?
The max supply of EV Biologics shares is 10.23M.
What is EV Biologics Price to Earnings Ratio (PE Ratio)?
EV Biologics PE Ratio is now.
What was EV Biologics earnings per share over the trailing 12 months (TTM)?
EV Biologics EPS is -0.18 USD over the trailing 12 months.
Which sector does the EV Biologics company belong to?
The EV Biologics sector is Healthcare.
EV Biologics YECO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 21356.17 USD — |
+0.87
|
— — | 20988.36 USD — | 21425.55 USD — | — - | — — |
- {{ link.label }} {{link}}